Halozyme Therapeutic (NQ: HALO )

43.03 USD +1.26 (+3.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
May 02, 2019
Form 4
Source: SEC/Edgar
April 14, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4
Source: SEC/Edgar
February 21, 2019
Form 4/A
Source: SEC/Edgar
February 19, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 14, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 13, 2019
Form 4
Source: SEC/Edgar
February 05, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
February 04, 2019
Form 4
Source: SEC/Edgar
December 09, 2018
Form 4
Source: SEC/Edgar
October 02, 2018
Form 3
Source: SEC/Edgar
September 13, 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.